Exousia Pro (MAJI) 주식 개요는 미국에서 대마초 제품을 유통합니다. 자세히 보기MAJI 펀더멘털 분석스노우플레이크 점수가치 평가0/6미래 성장0/6과거 실적0/6재무 건전성0/6배당0/6위험 분석수익이 USD$1m 미만입니다($-13K)지난 3개월 동안 주가 변동성이 US 시장과 비교했을 때 매우 높았습니다.마이너스 주주 지분의미 있는 시가총액이 없습니다($617K)+ 위험 2건 추가모든 위험 점검 보기MAJI Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$0.011해당 없음내재 할인율Est. Revenue$PastFuture-807k4082016201920222025202620282031Revenue US$1.0Earnings US$0.2AdvancedSet Fair ValueView all narrativesExousia Pro, Inc. 경쟁사Lipella PharmaceuticalsSymbol: OTCPK:LIPOMarket cap: US$462.1kPropanc BiopharmaSymbol: NasdaqCM:PPCBMarket cap: US$1.5mBeroni GroupSymbol: OTCPK:BNIG.FMarket cap: US$217.5kScinai ImmunotherapeuticsSymbol: NasdaqCM:SCNIMarket cap: US$1.8m가격 이력 및 성과Exousia Pro 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가US$0.01152주 최고가US$0.2152주 최저가US$0.0092베타-4.871개월 변동-43.69%3개월 변동-70.86%1년 변동-94.50%3년 변동-89.00%5년 변동-93.82%IPO 이후 변동-99.75%최근 뉴스 및 업데이트공시 • May 12NexTel Medical Corp Enters Final Stage for Commercial LaunchNexTel Medical Corp. announced the commencement of the final stability phase for its inaugural line of commercial exosome products. Last week, NexTel successfully initiated the stability testing phase, a critical precursor to market entry. Under the supervision of Lab Director and Dr. Hausman, a production batch underwent rigorous filtration and diagnostic screening. Utilizing advanced PCR technology, samples were tested for common contaminants, using a threshold of (“0”), including: Shiga-like toxin-producing E. coli, Salmonella, Pseudomonas aeruginosa, Staphylococcus aureus. The samples tested negative for all four organisms. Currently, stability vials are being monitored at both room temperature and refrigeration. Success at the 30-day mark will allow NexTel to proceed with an immediate commercial launch, establishing a definitive shelf life for additive-free, pure exosome products.공시 • Mar 17Exousia Pro, Inc. Announces Favorable Litigation Settlement Highlighting Significant Debt Elimination And Share Cancellation To Enhance Shareholder ValueExousia Pro, Inc. had announced the successful settlement of its outstanding litigation involving a former Director. This landmark agreement represents a pivotal financial milestone for the Company, delivering immediate and substantial value to current shareholders by improving the capital structure and strengthening the balance sheet. Under the terms of the settlement, which is expected to close within 30 days, Exousia Pro will make a one-time, strategic payment of $147,500 to the involved parties. In exchange, the Company will secure highly favorable financial restructuring outcomes. For the purposes of the Company’s upcoming financial reporting and audits, these events will be recorded under Generally Accepted Accounting Principles (GAAP) and will provide the following distinct benefits to the Company and its shareholders: Significant Debt Reduction: The settlement triggers the complete cancellation of a $200,000 promissory note issued at closing, as well as the cancellation of the remaining balance on the note tied to the control block of Preferred Stock. Removing these liabilities immediately strengthens Exousia's balance sheet and frees up future cash flow. Reversal of Share Dilution: The agreement secures the cancellation and return to treasury of 6,297,511 shares of Common Stock. Retiring this sizable block of shares reverses prior dilution, directly increasing the equity value, earnings-per-share potential, and ownership percentage of all current shareholders. Enhanced Audit Readiness and Transparency: By formally clearing these contested liabilities and equity issuances from the general ledger under GAAP, the Company is positioned for a clean, streamlined audit. This provides greater financial transparency and reinforces confidence within the investment community. By resolving this legacy dispute efficiently, Exousia Pro’s management team can now focus entirely on advancing its core clinical pipeline and expanding its telehealth initiatives without the distraction or financial overhang of litigation.공시 • Nov 18LAMY (OTCPK:LMMY) entered into an agreement to acquire Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) for $10.6 million.LAMY (OTCPK:LMMY) entered into an agreement to acquire Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) for $10.6 million on November 11, 2025. For consideration, 62.22 million shares of LAMY common stock will be given to the shareholders of Exousia Ai. The trannsaction was subject to approval from LAMY board and the same was approved. LAMY (OTCPK:LMMY) completed the acquisition of Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) on November 17, 2025.공시 • Jan 07Marijuana Inc. (OTCPK:MAJI) acquired Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG).Marijuana Inc. (OTCPK:MAJI) acquired Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG) on January 6, 2025. As part of consideration, cash and stock of 47 million restricted shares of its Common stock is paid to Ludwig Enterprises. Marijuana Inc. further agreed to assume liabilities under $0.075 million and issued Ludwig a Note for $0.1 million. Marijuana Inc. (OTCPK:MAJI) completed the acquisition of Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG) on January 6, 2025.공시 • May 24GRN Holding Corporation (OTCPK:GRNF) acquired Marijuana, Inc.GRN Holding Corporation (OTCPK:GRNF) acquired Marijuana, Inc. on May 23, 2023. As a result of the merger, existing equity holders of Marijuana Inc. have exchanged their shares for equity in the consolidated public company. The combined entity is poised to capitalize on the synergies between the two organizations, fostering operational efficiencies and unlocking new avenues for value creation. GRN Holding Corporation (OTCPK:GRNF) completed the acquisition of Marijuana, Inc. on May 23, 2023.공시 • Aug 06+ 1 more updateGRN Holdings Corporation, Inc. Appoints Donald Steinberg as DirectorGRN Holdings Corporation Inc. announced the appointment of Donald Steinberg as Director, the Company’s former CEO, has resigned from the Company’s board of directors, leaving Donald Steinberg as the Company’s sole director. Don has decades of involvement in the Marijuana Industry, going back to the 70’s when he was noted as the largest importer of Marijuana into the U.S. While in Marijuana “college” he studied stock options and wrote option volatility programs that he implemented on all of the option exchanges in the U.S. After that and seeing the large use of phone cards in Europe, he founded GlobalCom2000 which became a premier phone card company in the U.S. namely with the 7-11 card, the 1st card in the U.S. with a corporate logo and distribution in hundreds of 7-11 stores. He then went on to create One World Communications, which became the largest telecom affiliate marketing company in the world with 187 offices and training centers in over 30 countries and 200,000 affiliates. After One World Communications, he created Club Vivanet to provide financial services. In 2009, he formed Medical Marijuana Inc., which was the 1st company to be on a U.S. stock market. After building the market cap of Medical Marijuana Inc. to a market cap of nearly $100 million, he retired to Florida. In 2015, he formed Marijuana Company of America and resigned in 2019. In that year, he formed Marijuana Strategic Ventures to assist companies in the “going public process”. He recently changed the name of that company to Mushrooms Inc. to participate in the Mushrooms industry.더 많은 업데이트 보기Recent updates공시 • May 12NexTel Medical Corp Enters Final Stage for Commercial LaunchNexTel Medical Corp. announced the commencement of the final stability phase for its inaugural line of commercial exosome products. Last week, NexTel successfully initiated the stability testing phase, a critical precursor to market entry. Under the supervision of Lab Director and Dr. Hausman, a production batch underwent rigorous filtration and diagnostic screening. Utilizing advanced PCR technology, samples were tested for common contaminants, using a threshold of (“0”), including: Shiga-like toxin-producing E. coli, Salmonella, Pseudomonas aeruginosa, Staphylococcus aureus. The samples tested negative for all four organisms. Currently, stability vials are being monitored at both room temperature and refrigeration. Success at the 30-day mark will allow NexTel to proceed with an immediate commercial launch, establishing a definitive shelf life for additive-free, pure exosome products.공시 • Mar 17Exousia Pro, Inc. Announces Favorable Litigation Settlement Highlighting Significant Debt Elimination And Share Cancellation To Enhance Shareholder ValueExousia Pro, Inc. had announced the successful settlement of its outstanding litigation involving a former Director. This landmark agreement represents a pivotal financial milestone for the Company, delivering immediate and substantial value to current shareholders by improving the capital structure and strengthening the balance sheet. Under the terms of the settlement, which is expected to close within 30 days, Exousia Pro will make a one-time, strategic payment of $147,500 to the involved parties. In exchange, the Company will secure highly favorable financial restructuring outcomes. For the purposes of the Company’s upcoming financial reporting and audits, these events will be recorded under Generally Accepted Accounting Principles (GAAP) and will provide the following distinct benefits to the Company and its shareholders: Significant Debt Reduction: The settlement triggers the complete cancellation of a $200,000 promissory note issued at closing, as well as the cancellation of the remaining balance on the note tied to the control block of Preferred Stock. Removing these liabilities immediately strengthens Exousia's balance sheet and frees up future cash flow. Reversal of Share Dilution: The agreement secures the cancellation and return to treasury of 6,297,511 shares of Common Stock. Retiring this sizable block of shares reverses prior dilution, directly increasing the equity value, earnings-per-share potential, and ownership percentage of all current shareholders. Enhanced Audit Readiness and Transparency: By formally clearing these contested liabilities and equity issuances from the general ledger under GAAP, the Company is positioned for a clean, streamlined audit. This provides greater financial transparency and reinforces confidence within the investment community. By resolving this legacy dispute efficiently, Exousia Pro’s management team can now focus entirely on advancing its core clinical pipeline and expanding its telehealth initiatives without the distraction or financial overhang of litigation.공시 • Nov 18LAMY (OTCPK:LMMY) entered into an agreement to acquire Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) for $10.6 million.LAMY (OTCPK:LMMY) entered into an agreement to acquire Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) for $10.6 million on November 11, 2025. For consideration, 62.22 million shares of LAMY common stock will be given to the shareholders of Exousia Ai. The trannsaction was subject to approval from LAMY board and the same was approved. LAMY (OTCPK:LMMY) completed the acquisition of Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) on November 17, 2025.공시 • Jan 07Marijuana Inc. (OTCPK:MAJI) acquired Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG).Marijuana Inc. (OTCPK:MAJI) acquired Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG) on January 6, 2025. As part of consideration, cash and stock of 47 million restricted shares of its Common stock is paid to Ludwig Enterprises. Marijuana Inc. further agreed to assume liabilities under $0.075 million and issued Ludwig a Note for $0.1 million. Marijuana Inc. (OTCPK:MAJI) completed the acquisition of Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG) on January 6, 2025.공시 • May 24GRN Holding Corporation (OTCPK:GRNF) acquired Marijuana, Inc.GRN Holding Corporation (OTCPK:GRNF) acquired Marijuana, Inc. on May 23, 2023. As a result of the merger, existing equity holders of Marijuana Inc. have exchanged their shares for equity in the consolidated public company. The combined entity is poised to capitalize on the synergies between the two organizations, fostering operational efficiencies and unlocking new avenues for value creation. GRN Holding Corporation (OTCPK:GRNF) completed the acquisition of Marijuana, Inc. on May 23, 2023.공시 • Aug 06+ 1 more updateGRN Holdings Corporation, Inc. Appoints Donald Steinberg as DirectorGRN Holdings Corporation Inc. announced the appointment of Donald Steinberg as Director, the Company’s former CEO, has resigned from the Company’s board of directors, leaving Donald Steinberg as the Company’s sole director. Don has decades of involvement in the Marijuana Industry, going back to the 70’s when he was noted as the largest importer of Marijuana into the U.S. While in Marijuana “college” he studied stock options and wrote option volatility programs that he implemented on all of the option exchanges in the U.S. After that and seeing the large use of phone cards in Europe, he founded GlobalCom2000 which became a premier phone card company in the U.S. namely with the 7-11 card, the 1st card in the U.S. with a corporate logo and distribution in hundreds of 7-11 stores. He then went on to create One World Communications, which became the largest telecom affiliate marketing company in the world with 187 offices and training centers in over 30 countries and 200,000 affiliates. After One World Communications, he created Club Vivanet to provide financial services. In 2009, he formed Medical Marijuana Inc., which was the 1st company to be on a U.S. stock market. After building the market cap of Medical Marijuana Inc. to a market cap of nearly $100 million, he retired to Florida. In 2015, he formed Marijuana Company of America and resigned in 2019. In that year, he formed Marijuana Strategic Ventures to assist companies in the “going public process”. He recently changed the name of that company to Mushrooms Inc. to participate in the Mushrooms industry.주주 수익률MAJIUS BiotechsUS 시장7D0.7%2.4%1.1%1Y-94.5%34.6%28.7%전체 주주 수익률 보기수익률 대 산업: MAJI은 지난 1년 동안 34.6%의 수익을 기록한 US Biotechs 산업보다 저조한 성과를 냈습니다.수익률 대 시장: MAJI은 지난 1년 동안 28.7%를 기록한 US 시장보다 저조한 성과를 냈습니다.주가 변동성Is MAJI's price volatile compared to industry and market?MAJI volatilityMAJI Average Weekly Movement29.7%Biotechs Industry Average Movement10.8%Market Average Movement7.2%10% most volatile stocks in US Market16.4%10% least volatile stocks in US Market3.1%안정적인 주가: MAJI의 주가는 지난 3개월 동안 US 시장보다 변동성이 컸습니다.시간에 따른 변동성: MAJI의 주간 변동성은 지난 1년간 36%에서 30%로 감소했지만 여전히 US 종목의 상위 75%보다 높습니다.회사 소개설립직원 수CEO웹사이트20103Don Steinbergwww.exousiapro.com는 미국에서 대마초 제품을 유통하는 회사입니다. 이 회사는 이전에 GRN 홀딩 코퍼레이션으로 알려졌으며 2024년 10월에 마리화나 주식회사로 사명을 변경했습니다. 는 2010년에 설립되었으며 플로리다주 에스테로에 본사를 두고 있습니다.더 보기Exousia Pro, Inc. 기초 지표 요약Exousia Pro의 순이익과 매출은 시가총액과 어떻게 비교됩니까?MAJI 기초 통계시가총액US$616.53k순이익 (TTM)-US$661.35k매출 (TTM)n/a-48.1x주가매출비율(P/S)-0.9x주가수익비율(P/E)MAJI는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표MAJI 손익계산서 (TTM)매출-US$12.83k매출원가US$0총이익-US$12.83k기타 비용US$648.52k순이익-US$661.35k최근 보고된 실적Mar 31, 2025다음 실적 발표일해당 없음주당순이익(EPS)-0.012총이익률100.00%순이익률5,154.75%부채/자본 비율-108.3%MAJI의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/25 21:16종가2026/05/22 00:00수익2025/03/31연간 수익2024/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Exousia Pro, Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • May 12NexTel Medical Corp Enters Final Stage for Commercial LaunchNexTel Medical Corp. announced the commencement of the final stability phase for its inaugural line of commercial exosome products. Last week, NexTel successfully initiated the stability testing phase, a critical precursor to market entry. Under the supervision of Lab Director and Dr. Hausman, a production batch underwent rigorous filtration and diagnostic screening. Utilizing advanced PCR technology, samples were tested for common contaminants, using a threshold of (“0”), including: Shiga-like toxin-producing E. coli, Salmonella, Pseudomonas aeruginosa, Staphylococcus aureus. The samples tested negative for all four organisms. Currently, stability vials are being monitored at both room temperature and refrigeration. Success at the 30-day mark will allow NexTel to proceed with an immediate commercial launch, establishing a definitive shelf life for additive-free, pure exosome products.
공시 • Mar 17Exousia Pro, Inc. Announces Favorable Litigation Settlement Highlighting Significant Debt Elimination And Share Cancellation To Enhance Shareholder ValueExousia Pro, Inc. had announced the successful settlement of its outstanding litigation involving a former Director. This landmark agreement represents a pivotal financial milestone for the Company, delivering immediate and substantial value to current shareholders by improving the capital structure and strengthening the balance sheet. Under the terms of the settlement, which is expected to close within 30 days, Exousia Pro will make a one-time, strategic payment of $147,500 to the involved parties. In exchange, the Company will secure highly favorable financial restructuring outcomes. For the purposes of the Company’s upcoming financial reporting and audits, these events will be recorded under Generally Accepted Accounting Principles (GAAP) and will provide the following distinct benefits to the Company and its shareholders: Significant Debt Reduction: The settlement triggers the complete cancellation of a $200,000 promissory note issued at closing, as well as the cancellation of the remaining balance on the note tied to the control block of Preferred Stock. Removing these liabilities immediately strengthens Exousia's balance sheet and frees up future cash flow. Reversal of Share Dilution: The agreement secures the cancellation and return to treasury of 6,297,511 shares of Common Stock. Retiring this sizable block of shares reverses prior dilution, directly increasing the equity value, earnings-per-share potential, and ownership percentage of all current shareholders. Enhanced Audit Readiness and Transparency: By formally clearing these contested liabilities and equity issuances from the general ledger under GAAP, the Company is positioned for a clean, streamlined audit. This provides greater financial transparency and reinforces confidence within the investment community. By resolving this legacy dispute efficiently, Exousia Pro’s management team can now focus entirely on advancing its core clinical pipeline and expanding its telehealth initiatives without the distraction or financial overhang of litigation.
공시 • Nov 18LAMY (OTCPK:LMMY) entered into an agreement to acquire Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) for $10.6 million.LAMY (OTCPK:LMMY) entered into an agreement to acquire Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) for $10.6 million on November 11, 2025. For consideration, 62.22 million shares of LAMY common stock will be given to the shareholders of Exousia Ai. The trannsaction was subject to approval from LAMY board and the same was approved. LAMY (OTCPK:LMMY) completed the acquisition of Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) on November 17, 2025.
공시 • Jan 07Marijuana Inc. (OTCPK:MAJI) acquired Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG).Marijuana Inc. (OTCPK:MAJI) acquired Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG) on January 6, 2025. As part of consideration, cash and stock of 47 million restricted shares of its Common stock is paid to Ludwig Enterprises. Marijuana Inc. further agreed to assume liabilities under $0.075 million and issued Ludwig a Note for $0.1 million. Marijuana Inc. (OTCPK:MAJI) completed the acquisition of Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG) on January 6, 2025.
공시 • May 24GRN Holding Corporation (OTCPK:GRNF) acquired Marijuana, Inc.GRN Holding Corporation (OTCPK:GRNF) acquired Marijuana, Inc. on May 23, 2023. As a result of the merger, existing equity holders of Marijuana Inc. have exchanged their shares for equity in the consolidated public company. The combined entity is poised to capitalize on the synergies between the two organizations, fostering operational efficiencies and unlocking new avenues for value creation. GRN Holding Corporation (OTCPK:GRNF) completed the acquisition of Marijuana, Inc. on May 23, 2023.
공시 • Aug 06+ 1 more updateGRN Holdings Corporation, Inc. Appoints Donald Steinberg as DirectorGRN Holdings Corporation Inc. announced the appointment of Donald Steinberg as Director, the Company’s former CEO, has resigned from the Company’s board of directors, leaving Donald Steinberg as the Company’s sole director. Don has decades of involvement in the Marijuana Industry, going back to the 70’s when he was noted as the largest importer of Marijuana into the U.S. While in Marijuana “college” he studied stock options and wrote option volatility programs that he implemented on all of the option exchanges in the U.S. After that and seeing the large use of phone cards in Europe, he founded GlobalCom2000 which became a premier phone card company in the U.S. namely with the 7-11 card, the 1st card in the U.S. with a corporate logo and distribution in hundreds of 7-11 stores. He then went on to create One World Communications, which became the largest telecom affiliate marketing company in the world with 187 offices and training centers in over 30 countries and 200,000 affiliates. After One World Communications, he created Club Vivanet to provide financial services. In 2009, he formed Medical Marijuana Inc., which was the 1st company to be on a U.S. stock market. After building the market cap of Medical Marijuana Inc. to a market cap of nearly $100 million, he retired to Florida. In 2015, he formed Marijuana Company of America and resigned in 2019. In that year, he formed Marijuana Strategic Ventures to assist companies in the “going public process”. He recently changed the name of that company to Mushrooms Inc. to participate in the Mushrooms industry.
공시 • May 12NexTel Medical Corp Enters Final Stage for Commercial LaunchNexTel Medical Corp. announced the commencement of the final stability phase for its inaugural line of commercial exosome products. Last week, NexTel successfully initiated the stability testing phase, a critical precursor to market entry. Under the supervision of Lab Director and Dr. Hausman, a production batch underwent rigorous filtration and diagnostic screening. Utilizing advanced PCR technology, samples were tested for common contaminants, using a threshold of (“0”), including: Shiga-like toxin-producing E. coli, Salmonella, Pseudomonas aeruginosa, Staphylococcus aureus. The samples tested negative for all four organisms. Currently, stability vials are being monitored at both room temperature and refrigeration. Success at the 30-day mark will allow NexTel to proceed with an immediate commercial launch, establishing a definitive shelf life for additive-free, pure exosome products.
공시 • Mar 17Exousia Pro, Inc. Announces Favorable Litigation Settlement Highlighting Significant Debt Elimination And Share Cancellation To Enhance Shareholder ValueExousia Pro, Inc. had announced the successful settlement of its outstanding litigation involving a former Director. This landmark agreement represents a pivotal financial milestone for the Company, delivering immediate and substantial value to current shareholders by improving the capital structure and strengthening the balance sheet. Under the terms of the settlement, which is expected to close within 30 days, Exousia Pro will make a one-time, strategic payment of $147,500 to the involved parties. In exchange, the Company will secure highly favorable financial restructuring outcomes. For the purposes of the Company’s upcoming financial reporting and audits, these events will be recorded under Generally Accepted Accounting Principles (GAAP) and will provide the following distinct benefits to the Company and its shareholders: Significant Debt Reduction: The settlement triggers the complete cancellation of a $200,000 promissory note issued at closing, as well as the cancellation of the remaining balance on the note tied to the control block of Preferred Stock. Removing these liabilities immediately strengthens Exousia's balance sheet and frees up future cash flow. Reversal of Share Dilution: The agreement secures the cancellation and return to treasury of 6,297,511 shares of Common Stock. Retiring this sizable block of shares reverses prior dilution, directly increasing the equity value, earnings-per-share potential, and ownership percentage of all current shareholders. Enhanced Audit Readiness and Transparency: By formally clearing these contested liabilities and equity issuances from the general ledger under GAAP, the Company is positioned for a clean, streamlined audit. This provides greater financial transparency and reinforces confidence within the investment community. By resolving this legacy dispute efficiently, Exousia Pro’s management team can now focus entirely on advancing its core clinical pipeline and expanding its telehealth initiatives without the distraction or financial overhang of litigation.
공시 • Nov 18LAMY (OTCPK:LMMY) entered into an agreement to acquire Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) for $10.6 million.LAMY (OTCPK:LMMY) entered into an agreement to acquire Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) for $10.6 million on November 11, 2025. For consideration, 62.22 million shares of LAMY common stock will be given to the shareholders of Exousia Ai. The trannsaction was subject to approval from LAMY board and the same was approved. LAMY (OTCPK:LMMY) completed the acquisition of Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) on November 17, 2025.
공시 • Jan 07Marijuana Inc. (OTCPK:MAJI) acquired Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG).Marijuana Inc. (OTCPK:MAJI) acquired Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG) on January 6, 2025. As part of consideration, cash and stock of 47 million restricted shares of its Common stock is paid to Ludwig Enterprises. Marijuana Inc. further agreed to assume liabilities under $0.075 million and issued Ludwig a Note for $0.1 million. Marijuana Inc. (OTCPK:MAJI) completed the acquisition of Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG) on January 6, 2025.
공시 • May 24GRN Holding Corporation (OTCPK:GRNF) acquired Marijuana, Inc.GRN Holding Corporation (OTCPK:GRNF) acquired Marijuana, Inc. on May 23, 2023. As a result of the merger, existing equity holders of Marijuana Inc. have exchanged their shares for equity in the consolidated public company. The combined entity is poised to capitalize on the synergies between the two organizations, fostering operational efficiencies and unlocking new avenues for value creation. GRN Holding Corporation (OTCPK:GRNF) completed the acquisition of Marijuana, Inc. on May 23, 2023.
공시 • Aug 06+ 1 more updateGRN Holdings Corporation, Inc. Appoints Donald Steinberg as DirectorGRN Holdings Corporation Inc. announced the appointment of Donald Steinberg as Director, the Company’s former CEO, has resigned from the Company’s board of directors, leaving Donald Steinberg as the Company’s sole director. Don has decades of involvement in the Marijuana Industry, going back to the 70’s when he was noted as the largest importer of Marijuana into the U.S. While in Marijuana “college” he studied stock options and wrote option volatility programs that he implemented on all of the option exchanges in the U.S. After that and seeing the large use of phone cards in Europe, he founded GlobalCom2000 which became a premier phone card company in the U.S. namely with the 7-11 card, the 1st card in the U.S. with a corporate logo and distribution in hundreds of 7-11 stores. He then went on to create One World Communications, which became the largest telecom affiliate marketing company in the world with 187 offices and training centers in over 30 countries and 200,000 affiliates. After One World Communications, he created Club Vivanet to provide financial services. In 2009, he formed Medical Marijuana Inc., which was the 1st company to be on a U.S. stock market. After building the market cap of Medical Marijuana Inc. to a market cap of nearly $100 million, he retired to Florida. In 2015, he formed Marijuana Company of America and resigned in 2019. In that year, he formed Marijuana Strategic Ventures to assist companies in the “going public process”. He recently changed the name of that company to Mushrooms Inc. to participate in the Mushrooms industry.
